ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.37A>G (p.Asn13Asp)

dbSNP: rs1597923586
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000824522 SCV000965422 uncertain significance Hereditary breast ovarian cancer syndrome 2021-03-14 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of experimental studies (such as gene expression, population dynamics, functional pathways, and cell-cycle effects in cell culture) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA1 protein function. This variant has not been reported in the literature in individuals with BRCA1-related conditions. ClinVar contains an entry for this variant (Variation ID: 666101). This variant is not present in population databases (ExAC no frequency). This sequence change replaces asparagine with aspartic acid at codon 13 of the BRCA1 protein (p.Asn13Asp). The asparagine residue is moderately conserved and there is a small physicochemical difference between asparagine and aspartic acid. This variant has been reported not to substantially affect BRCA1 protein function (PMID: 30209399).
Brotman Baty Institute, University of Washington RCV001077672 SCV001243634 not provided Breast-ovarian cancer, familial, susceptibility to, 1 no assertion provided in vitro

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.